Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Cereb Blood Flow Metab ; 37(4): 1508-1516, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27389176

ABSTRACT

Amnestic mild cognitive impairment represents an early stage of Alzheimer's disease, and characterization of physiological alterations in mild cognitive impairment is an important step toward accurate diagnosis and intervention of this condition. To investigate the extent of neurodegeneration in patients with mild cognitive impairment, whole-brain cerebral metabolic rate of oxygen in absolute units of µmol O2/min/100 g was quantified in 44 amnestic mild cognitive impairment and 28 elderly controls using a novel, non-invasive magnetic resonance imaging method. We found a 12.9% reduction ( p = 0.004) in cerebral metabolic rate of oxygen in mild cognitive impairment, which was primarily attributed to a reduction in the oxygen extraction fraction, by 10% ( p = 0.016). Global cerebral blood flow was not found to be different between groups. Another aspect of vascular function, cerebrovascular reactivity, was measured by CO2-inhalation magnetic resonance imaging and was found to be equivalent between groups. Therefore, there seems to be a global, diffuse diminishment in neural function in mild cognitive impairment, while their vascular function did not show a significant reduction.


Subject(s)
Amnesia/metabolism , Brain/diagnostic imaging , Cerebrovascular Circulation/physiology , Cognitive Dysfunction/metabolism , Magnetic Resonance Imaging/methods , Oxygen/metabolism , Aged , Amnesia/diagnostic imaging , Amnesia/physiopathology , Brain/blood supply , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/physiopathology , Female , Fluorodeoxyglucose F18 , Humans , Male , Middle Aged , Oxygen/blood , Radiopharmaceuticals
SELECTION OF CITATIONS
SEARCH DETAIL
...